clinical trial · NCT04044768
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
USWM CT, LLC·phase2·active not recruiting·n = 52
Synovial SarcomaMyxoid Liposarcomaafamitresgene autoleucel (previously ADP-A2M4)
brief summary
This is a study to investigate the efficacy and safety of ADP-A2M4 in HLA-A\*02 eligible and MAGE-A4 positive subjects with metastatic or inoperable (advanced) Synovial Sarcoma (Cohort 1, 2 and 3 ) or MRCLS (Cohort 1) .
started
Aug 13, 2019
primary completion
Aug 29, 2021
completion
Apr 1, 2038
last updated
Feb 6, 2026
official title
A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR™ T Cells in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol